Well, Hoppity your argument is valid only if the drug companies are all run by Darth Vader-esque monsters only interested in money. As you know, reality is more complex. Biotech companies, researchers and executives typically are interested in BOTH making money and providing medical treatments. Adult stem cell research hasn’t had the restrictions that embryonic stem cell research has had, so people have gotten funding and developed cures using it. In no way does that disprove a motive to try to use patents in developing embryonic stem cell ‘treatments.’ Nobody claimed they are ONLY interested in money, so you are reasoning against an argument not made.
I think it is a BAD strategy to argue that embryonic stem cells haven’t yielded any viable treatment and adult stem cells have and therefore, we should put money into the adult kind. Such thinking sets us up for collapse if an effective ‘treatment’ DOES come out. Nobody would argue about ‘effectiveness’ of a therapy developed via kidnapping and killing older kids, would they? Why are we? It’s just a short sighted strategy that will hurt the cause in the long run. And this is going to be a LOOONNNGGG fight, I’m afraid.